Search

everythinglearnresearchcommunity

for

Search:↓

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Higher DHT in male baldness may protect against prostate cancer.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Large prostates link to more hair loss.

Finasteride treats hair loss but may affect prostate cancer detection.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.